ArticleRadiation oncology journal2022

PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy.

Ick Joon Cho et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.